CRISPR-based oligo recombineering prioritizes apicomplexan cysteines for drug discovery

H. J. Benns, M. Storch, J. A. Falco, F. R. Fisher, Fabio Tamaki, E. Alves, C. J. Wincott, Rachel Milne, Natalie Wiedemar, G. Craven, Beatriz Baragaña, Susan Wyllie, Jake Baum, G. S. Baldwin, Eranthie Weerapana, Edward W. Tate, M. A. Child

Drug Discovery Unit
Biological Chemistry and Drug Discovery

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

101 Downloads (Pure)

1 results

Active
Wellcome Centre for Anti-Infectives Research
Cook, S. (Investigator), De Rycker, M. (Investigator), Fairlamb, A. (Investigator), Ferguson, M. (Investigator), Field, M. (Investigator), Gilbert, I. (Investigator), Gray, D. (Investigator), Horn, D. (Investigator), Pawlowic, M. C. (Investigator), Read, K. (Investigator), Wyatt, P. (Investigator) & Wyllie, S. (Investigator)
1/04/17 → 31/03/25
Project: Research

CRISPR-based oligo recombineering prioritizes apicomplexan cysteines for drug discovery

Projects

Search results

Wellcome Centre for Anti-Infectives Research